A detailed history of Efg Asset Management (North America) Corp. transactions in Boston Scientific Corp stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 38,329 shares of BSX stock, worth $2.93 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
38,329
Previous 38,528 0.52%
Holding current value
$2.93 Million
Previous $2.23 Million 17.87%
% of portfolio
0.46%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $11,462 - $13,655
-199 Reduced 0.52%
38,329 $2.63 Million
Q4 2023

Feb 08, 2024

BUY
$48.64 - $57.81 $1.02 Million - $1.21 Million
20,880 Added 118.31%
38,528 $2.23 Million
Q3 2023

Nov 02, 2023

SELL
$50.19 - $54.68 $18,720 - $20,395
-373 Reduced 2.07%
17,648 $931,000
Q2 2023

Jul 28, 2023

BUY
$49.72 - $54.64 $896,004 - $984,667
18,021 New
18,021 $974,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.